References
- Rudzki E, Kolowska A. Causes of chromate dermatitis in Poland. Contact Dermatitis 1980; 6: 191–6
- Fregart S. Occupational dermatitis in ten year material. Contact Dermatitis 1975; 1: 96–107
- Flori L, Perotti R, Mazzatenta C, et al. Cyclosporin A in the treatment of severe allergic contact dermatitis. J Eur Acad Derm-Venereol 1993; 2: 200–6
- De Rie M A, Meinardi M M, Bos J D. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis. Acta Derm Venereol (Stockh) 1991; 71: 452–4
- Roed-Petersen J, Thomsen K. Azathioprine in the treatment of airborne contact dermatitis from compositae oleoresins and sensitivity to UVA. Acta Derm Venereol (Stockh) 1980; 60: 275–7
- Younger I R, Harris D WS, Colver G B. Azathioprine in dermatology. J Am Acad Dermatol 1992; 25: 281–6
- Snow J L, Gibson L E. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients. Arch Dermatol 1995; 131: 193–7
- Connel W R, Kamm M A, Dickson M, et al. Long term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249–52
- Bennett J A, Christian J M. Cyclosporin induced gingival hyperplasia: case report and literature review. J Am Dent Assoc 1985; 3: 272–3
- Bunney M H, Benton E C, Barr B B, et al. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin compared with those receiving azathioprine. Nephrol Dial Transplant 1990; 5: 379–82